ATC Group: S01BA Corticosteroids, plain

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01BA in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01B Antiinflammatory agents
4 S01BA Corticosteroids, plain

Group S01BA contents

Code Title
S01BA01 Dexamethasone
S01BA02 Hydrocortisone
S01BA03 Cortisone
S01BA04 Prednisolone
S01BA05 Triamcinolone
S01BA06 Betamethasone
S01BA07 Fluorometholone
S01BA08 Medrysone
S01BA09 Clobetasone
S01BA10 Alclometasone
S01BA11 Desonide
S01BA12 Formocortal
S01BA13 Rimexolone
S01BA14 Loteprednol
S01BA15 Fluocinolone acetonide
S01BA16

Active ingredients in S01BA

Active Ingredient

Alclometasone dipropionate is a non-fluorinated, topically active synthetic corticosteroid. Pharmacological studies in man and animals have demonstrated that alclometasone dipropionate suppresses local inflammation at doses producing minimal systemic effects.

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Clobetasone is a topical corticosteroids. Clobetasone has little effect on hypothalamo-pituitary-adrenal function. Clobetasone is less potent than other available corticosteroid preparations and has been shown not to suppress the hypothalamo-pituitary-adrenal axis in patients treated for psoriasis or eczema.

Cortisone is a man-made version of a natural hormone called cortisol (corticosteroid hormone). It is a naturally-occurring corticosteroid metabolite that is also used as a pharmaceutical prodrug. Cortisol is converted by the action of the enzyme corticosteroid 11-beta-dehydrogenase isozyme 2 into the inactive metabolite cortisone, particularly in the kidneys. This is done by oxidizing the alcohol group at carbon 11 (in the six-membered ring fused to the five-membered ring). Cortisone is converted back to the active steroid cortisol by stereospecific hydrogenation at carbon 11 by the enzyme 11β-Hydroxysteroid dehydrogenase type 1, particularly in the liver. Cortisol decreases your body’s natural defensive response and reduces symptoms such as swelling and allergic-type reactions. This medication is used to treat conditions such as arthritis, blood/hormone/immune system disorders, allergic reactions, certain skin and eye conditions, breathing problems, and certain cancers.

Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.

Difluprednate is a topical corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery. Corticosteroids inhibit the inflammatory response to a variety of inciting agents and may delay or slow healing. There is no generally accepted explanation for the mechanism of action of ocular corticosteroids.

Fluocinolone acetonide is a synthetic fluorinated corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties.

Fluorometholone is a synthetic corticosteroid (glucocorticoid), a derivative of desoxyprednisolone. It is a member of the group of universally known steroids used for the treatment of eye inflammation. Glucocorticosteroids bind to cytoplasmic receptors and control the synthesis of infection mediators thus damping inflammatory reactions (swelling, fibrin deposition, capillary dilatation, phagocyte migration) and also capillary proliferation, collagen deposition and scarring.

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.

Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure.

Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems.

Rimexolone is a corticosteroid drug. Placebo controlled clinical studies demonstrated that rimexolone is efficacious for the treatment of anterior chamber inflammation following cataract surgery.

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect.

Related product monographs

Document Type Information Source  
 ALREX Ophthalmic suspension MPI, US: SPL/Old FDA, National Drug Code (US)
 DECADRON Oral solution MPI, US: SPL/Old FDA, National Drug Code (US)
 DROPODEX Eye drops, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 FLAREX Eye drops, suspension MPI, US: SPL/Old FDA, National Drug Code (US)
 FML Eye drops, suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ILUVIEN Intravitreal implant MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 LOTEMAX Eye-drops, suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 MAXIDEX Eye drops, suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 OZURDEX Intravitreal implant in applicator MPI, EU: SmPC European Medicines Agency (EU)
 PRED FORTE Eye drops, suspension MPI, US: SPL/Old FDA, National Drug Code (US)
 PRED MILD Eye-drops, suspension MPI, US: SPL/Old FDA, National Drug Code (US)
 RETISERT Implant MPI, US: SPL/PLR FDA, National Drug Code (US)
 VEXOL Eye drops, suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)